Reducing Plasma Glucose Effect of Cinnamon in Type 2 Diabetic Patients in the Municipality of Com… (NCT03711682) | Clinical Trial Compass
CompletedPhase 2/3
Reducing Plasma Glucose Effect of Cinnamon in Type 2 Diabetic Patients in the Municipality of Comasagua
El Salvador30 participantsStarted 2018-03-01
Plain-language summary
The aim of the study is evaluate the effect of cinnamon powder (Cinnamomum verum) on the glycaemia and HbA1c (Glycohemoglobin) of type 2 diabetic Salvadoran patients, whose hypoglycemic treatment is only Metformin. To carry out this objective, subjects who agree to be part of the study will subjected to measurements of their body weight, height, body mass index, waist circumference, systolic pressure, diastolic pressure, capillary glucose (with glucose meter) every 2 weeks, and their glycohemoglobin (HbA1c) at the beginning and at the end of the study.
Who can participate
Age range40 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Clinical diagnosis of Type 2 Diabetes mellitus.
* Treated only with Metformin as unique treatment for diabetes.
Exclusion Criteria:
* Hypersensitivity or allergy reported to Cinnamomum spp. or Peruvian balm.
* Ulcer of gastrointestinal location.
* Chronic treatment with analgesics, antibiotics, estrogens, antineoplastics, antihypertensives of the beta-blocker type, anti-inflammatory, medications whose route of action is Gamma-Aminobutyric Acid and / or anticoagulants.
* Under treatment with steroid and / or aspirin.
* Subject that use alternative medicine treatments.
* Women of childbearing age who do not use any contraceptive method.
* Subjects subjected to surgical procedures in the 6 weeks prior to the beginning of the study.
* Subjects who presented fasting glycemia levels greater than 400 mg/dL in the previous control.
* Allergies to wheat and/or diagnosed with celiac disease.
* Adverse Drug Reaction during the study.
* Subjects whose treatment schedule changed during the study intervention.
* Subjects that does not accept to be part of the study, decides to leave the study or does not have adherence to the treatment provided.